Income Tax Expense (Benefit) of Niagen Bioscience, Inc. from 03 Jan 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Niagen Bioscience, Inc. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 03 Jan 2015 to 31 Dec 2025.
  • Niagen Bioscience, Inc. Income Tax Expense (Benefit) for the quarter ending 31 Dec 2025 was $292,000, a 4.3% decline year-over-year.
  • Niagen Bioscience, Inc. Income Tax Expense (Benefit) for the twelve months ending 31 Dec 2025 was $810,000, a 166% increase year-over-year.
  • Niagen Bioscience, Inc. annual Income Tax Expense (Benefit) for 2025 was $810,000, a 166% increase from 2024.
  • Niagen Bioscience, Inc. annual Income Tax Expense (Benefit) for 2024 was $305,000.
  • Niagen Bioscience, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

Niagen Bioscience, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $810,000 $292,000 -$13,000 -4.3% 01 Oct 2025 31 Dec 2025 10-K 04 Mar 2026 2025 FY
Q3 2025 $823,000 $222,000 +$222,000 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $601,000 $128,000 +$128,000 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $473,000 $168,000 +$168,000 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $305,000 $305,000 01 Oct 2024 31 Dec 2024 10-K 04 Mar 2026 2025 FY
Q3 2024 $0 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 $0 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 $0 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q2 2017 $6,653 $0 -$4,087 -100% 02 Apr 2017 01 Jul 2017 10-Q 10 Aug 2017 2017 Q2
Q1 2017 $10,740 $0 +$10,740 01 Jan 2017 01 Apr 2017 10-Q 11 May 2017 2017 Q1
Q4 2016 $0 $3,500 -$1,027 -23% 02 Oct 2016 31 Dec 2016 10-K 15 Mar 2018 2017 FY
Q3 2016 $1,027 $3,153 +$3,153 03 Jul 2016 01 Oct 2016 10-K 15 Mar 2018 2017 FY
Q2 2016 $2,126 $4,087 +$4,087 03 Apr 2016 02 Jul 2016 10-K 15 Mar 2018 2017 FY
Q1 2016 $6,213 $10,740 -$10,740 03 Jan 2016 02 Apr 2016 10-K 15 Mar 2018 2017 FY
Q4 2015 $4,527 $4,527 04 Oct 2015 02 Jan 2016 10-K 16 Mar 2017 2016 FY
Q3 2015 $0 05 Jul 2015 03 Oct 2015 10-K 16 Mar 2017 2016 FY
Q2 2015 $0 05 Apr 2015 04 Jul 2015 10-K 16 Mar 2017 2016 FY
Q1 2015 $0 03 Jan 2015 04 Apr 2015 10-Q 12 May 2016 2016 Q1

Niagen Bioscience, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $810,000 +$505,000 +166% 01 Jan 2025 31 Dec 2025 10-K 04 Mar 2026 2025 FY
2024 $305,000 +$305,000 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2026 2025 FY
2023 $0 01 Jan 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
2017 $0 $0 01 Jan 2017 30 Dec 2017 10-K 15 Mar 2018 2017 FY
2016 $0 +$4,527 03 Jan 2016 31 Dec 2016 10-K 15 Mar 2018 2017 FY
2015 $4,527 -$4,527 04 Jan 2015 02 Jan 2016 10-K 15 Mar 2018 2017 FY
2014 $0 29 Dec 2013 03 Jan 2015 10-K 16 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.